Tech Company Financing Transactions
TrialScope Funding Round
Private investors participated in a $4 million funding round for TrialScope. The round was announced on 9/18/2018.
Transaction Overview
Company Name
Announced On
9/18/2018
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
185 Hudson St. Harborside Five 2900
Jersey City, NJ 07311
USA
Jersey City, NJ 07311
USA
Phone
Website
Email Address
Overview
TrialScope is the global leader in clinical trial transparency and compliance. Our tools and systems enable our customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Kozloff
Chief Operating Officer
Thomas Wicks
VP - Bus. Development
Daniel Lehman
VP - Customer Service
David Laky
VP - Finance
Matthew Patras
VP - Marketing
Naor Chazan
Browse more venture capital transactions:
Prev: 9/18/2018: FlexGen Power Systems venture capital transaction
Next: 9/18/2018: Pivotal Commware venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs